The results of Novo Nordisk’s phase 1 trials shows the oral weight loss pill could be more effective than semaglutide.

Heading into a gluttonous time of year in the U.S. with Halloween, Thanksgiving and Christmas on deck, it might be a bad time for Americans to find out their obesity rates continue to climb.

CEO Lars Fruergaard Jørgensen was grilled by a U.S. Senate committee, Cantor Fitzgerald Managing Director Louise Chen noted ...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...

Novo Nordisk's top executive faced a Senate grilling on Tuesday over the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both injections soars in the ...

While several factors predict sustained glycemic control, predictors of sustained weight control with tirzepatide appear ...

During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced toug ...

Sen. Bernie Sanders grilled the maker of Wegovy and Ozempic on why the drugs cost so much more in the U.S. than in European countries.

While Congress debates the high cost of brand-name diabetes and weight loss drugs, Atlanta doctors are selling lower-cost alternatives made by compounding pharmacies.

Novo Nordisk and Eli Lilly are expected to rule the obesity market for a few more years without much challenge. To ensure they stay there as competition enters, the companies are spending billions in ...

What I am asking you is, if you don’t act, 40,000 people a year could die? Is this acceptable to you?” the senator asked.

Sen. Bernie Sanders mentioned that North Carolina ended coverage of Wegovy for state employees due to the cost.